A Yes or a No? Decicive Factors Behind Recommendations Made by the Danish Health Technology Council
Author(s)
Liljenberg D
The Danish Health Technology Council, Aalborg, 81, Denmark
Description: DHTC methods dictate that four perspectives are to be examined in HTAs of health technologies: clinical effectiveness and safety, the patients’ perspective, organizational implications, and health economics. Covering these four perspectives, the Council is to decide if a health technology should be recommended for national implementation. By comparing two HTAs, with a recommendation for and against national implementation, respectively, decisive factors for the recommendation outcomes are identified.
Lessons Learned: DHTC emphasized the following elements as decisive for their recommendations:
The use of glucose monitors:
- Leads to pronounced positive effects on several clinical outcomes
- Has compelling, positive consequences for patients, with potential to improve patients’ treatment satisfaction, quality of life, and insight into treatment and disease
- Is supported by a solid evidence base
- Is appraised by clinicians as a valuable tool for improving quality of treatment and communication with patients
In contrast, the use of AI:
- Might constitute a risk to patient safety, if leading to the collection of unnecessary tissue samples with the risks this entails
- Has not been evaluated with respect to patient-relevant outcomes
- Is supported by an inadequate evidence base
- Does not usefully support clinicians’ decision-making, who often opt out of using the AI-function
Stakeholder perspective: DHTC bases its recommendation on a consideration of multiple factors, where patient-centeredness, perceived value amongst clinicians, and the solidity of the evidence base supporting the use of the technology were emphasized as pivotal for the outcome of the national recommendations.
Conference/Value in Health Info
Value in Health, Volume 26, Issue 11, S2 (December 2023)
Acceptance Code
CS17
Topic
Health Policy & Regulatory, Health Technology Assessment
Topic Subcategory
Decision & Deliberative Processes, Public Spending & National Health Expenditures, Reimbursement & Access Policy
Disease
Medical Devices, no-additional-disease-conditions-specialized-treatment-areas